5‑Hydroxymethylcytosine as a Potential Epigenetic Biomarker in Papillary Thyroid Carcinoma

Oncology Letters - Greece
doi 10.3892/ol.2019.10531
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

A Potential Biomarker Hsa-miR-200a-5p Distinguishing Between Benign Thyroid Tumors With Papillary Hyperplasia and Papillary Thyroid Carcinoma

PLoS ONE
Multidisciplinary
2018English

Gene Body Profiles of 5-Hydroxymethylcytosine: Potential Origin, Function and Use as a Cancer Biomarker

Epigenomics
Cancer ResearchGenetics
2018English

Serum MMP-2 as a Potential Predictive Marker for Papillary Thyroid Carcinoma

PLoS ONE
Multidisciplinary
2018English

Thyroid: Papillary Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Papillary Thyroid Carcinoma

Archives of Surgery
2000English

Papillary Thyroid Carcinoma

Archives of Surgery
1998English

Papillary Thyroid Carcinoma in a Thyroglossal Cyst

Indian Journal of Otolaryngology and Head and Neck Surgery
OtorhinolaryngologySurgery
2003English

Papillary Thyroid Carcinoma in a Hemiagenetic Thyroid Gland: A Case Report

Turkish Journal of Endocrinology and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Low-Risk Papillary Thyroid Carcinoma

Revista de Medicina
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy